主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
S
SCHB
Schwab U.S. Broad Market ETF
28.6
4
USD
+0.67%
版块:
金融
基础:
USD
利润货币:
USD
日范围
年范围
日变化
+0.67%
每月变动
+0.81%
6个月变化
+8.81%
年变化
+23.71%
前一天收盘价
28.4
5
Open
28.6
0
最低价
28.6
0
High
28.6
6
交易量
214
市场
US ETFs
SCHB
1W
1M
3M
6M
YTD
1Y
5Y
展开完整图表
概览
所有持仓
热图
主要持股
Market Value
Shares
Weight %
S
SLNO
Soleno Therapeutics Inc
1.098 M
28.115 K
0.003%
IOSP
Innospec Inc
1.098 M
14.337 K
0.003%
KMPR
Kemper Corp
1.096 M
33.923 K
0.003%
RNG
RingCentral Inc
1.096 M
30.078 K
0.003%
A
ASGN
ASGN Inc
1.093 M
25.480 K
0.003%
LTC
LTC Properties Inc
1.088 M
27.419 K
0.003%
OMCL
Omnicell Inc
1.086 M
26.432 K
0.003%
PPC
Pilgrim's Pride Corp
1.086 M
25.161 K
0.003%
NNI
Nelnet Inc
1.085 M
8 378.000
0.003%
NKTR
Nektar Therapeutics
1.079 M
15.648 K
0.003%
LUNR
Intuitive Machines Inc
1.070 M
64.932 K
0.003%
FMC
FMC Corp
1.069 M
72.555 K
0.003%
TILE
Interface Inc
1.068 M
33.929 K
0.003%
AGYS
Agilysys Inc
1.068 M
14.795 K
0.003%
GNL
Global Net Lease Inc
1.066 M
113.128 K
0.003%
BLBD
Blue Bird Corp
1.065 M
18.273 K
0.003%
CNS
Cohen & Steers Inc
1.064 M
15.914 K
0.003%
SRPT
Sarepta Therapeutics Inc
1.063 M
63.450 K
0.003%
CLMT
Calumet Inc
1.063 M
39.417 K
0.003%
HROW
Harrow Inc
1.062 M
19.602 K
0.003%
1
...
72
73
74
75
76
77
...
121
新闻
SCHB: SCHB: A Hold Amid Premium Valuations And Higher Risk-Free Rates (NYSEARCA:SCHB)
Large Caps - Big Opportunity
3 Reasons Why I Remain Bullish On SCHB, And 2 To Sell It Immediately (NYSEARCA:SCHB)
Q1 2026 Dividend Check-In: Highest Quarterly Hike Percentage Since 2019
Big Tech's $635B AI Push Meets Energy Crunch: ETFs to Diversify
Patience Pays: ETFs You Can Buy and Hold for the Long Run
3 Best ETFs to Invest In, According to AI Analyst, 2/5/2026 - TipRanks.com
SCHB: The Conflict Between Short- And Long-Term Risks (NYSEARCA:SCHB)
ETFs to Keep Your Portfolio on Track in the Long Term
SCHB: Core Equity Holding For Diversified Investors (NYSEARCA:SCHB)
Capital Markets Outlook Q4 2025: Kicking The Can Down The Tightrope
Equity Outlook: From Caution To Complacency?